Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
In accordance with ICH Q8/9/10 and the FDA QbD initiative, companies are adding more and more PAT equipment, installing more sophisticated control systems, and moving to real-time release. Throughout this process, many questions have come to light. How is PAT justified for controlling quality attributes? How is PAT incorporated into the overall control strategy? What is needed for to validate a PAT system? These questions will be answered in a case study of using PAT to monitor and control the critical quality attribute of particle size in a production setting.
Professional Development Hours
0.50 PDHs
Presenter(s):
Preview Presentation:
Watch the following preview of this presentation.
Would you like to access this content?
No problem. You just have to complete the following steps.
You have completed 0 of 2 steps.
-
Log in
You must be logged in to view this content. Log in now.
-
Purchase Technical Presentation
You must purchase this technical presentation using one of the options below.
If you already purchased this content recently, please click here to refresh the system's record of ownerships.
Pricing
| Credits | 0.5 Use credits |
| List Price | $25.00 Buy now |
| AIChE Members | $15.00 Buy now |
| AIChE Undergraduate Student Members | Free Free access |
| AIChE Graduate Student Members | $15.00 Buy now |
Related Topics: